Headhunting Talented Individuals within Clinical Operations & Clinical Development for growing organizations across the US & Europe
Exciting news for the oncology community as MSD's Keytruda has received expanded FDA approval for use in combination with chemotherapy for the treatment of advanced cervical cancer! 🎉 This decision comes after promising results from the phase 3 KEYNOTE-826 trial, which demonstrated a significant improvement in progression-free survival for patients receiving the combination treatment. This approval represents a significant advancement in the fight against cervical cancer and provides hope for patients who are facing this challenging diagnosis. It also underscores the importance of ongoing research and development efforts in the field of oncology ✅🔍📈 It's humbling to see the ongoing commitment to the fight against cancer and continued efforts on the journey towards improving cancer treatments - Amazing work! 💊👏🏼 #Oncology #CervicalCancer #KeytrudaApproval #Biotechnology #Pharmaceuticals #ClinicalResearch #ClinicalTrials #LifeScience #ElxirAssociates #StaffingPartner